Allergy to betalactams and nucleotide-binding oligomerization domain (NOD) gene polymorphisms

A. C. Bursztejn, A. Romano, R. M. Guéant-Rodriguez, J. A. Cornejo, A. Oussalah, C. Chery, I. Gastin, F. Gaeta, A. Barbaud, M. Blanca, J. L. Guéant

Research output: Contribution to journalArticlepeer-review


Background Polymorphisms of interleukin genes related to IgE production and inflammation are predictors of hypersensitivity to betalactam, but nothing is known on the influence of NOD genes, despite their association with inflammation and atopy. Objective To evaluate the association of NOD2 and NOD1 polymorphisms with betalactam allergy. Method We genotyped 3 polymorphisms of NOD2 and 1 of NOD1 in 368 Italian and 387 Spanish patients, compared with 368 and 326 controls, respectively. Results CT/TT genotypes of rs2066845 of NOD2 predicted a lower risk in Italy (P = 0.003), while WT/insC genotype of rs5743293 (also in leucine-rich repeat domain) predicted a higher risk in Spain (P = 0.007). G allele of rs2066845 was associated with a higher level of IgE in the Italian population. Conclusion The mirrored influence of these NOD2 polymorphisms on betalactam allergy in two populations suggests a link with pathways of inflammation and/or atopy through mechanisms, which need to be clarified.

Original languageEnglish
Pages (from-to)1076-1080
Number of pages5
JournalAllergy: European Journal of Allergy and Clinical Immunology
Issue number8
Publication statusPublished - Aug 2013


  • betalactam allergy
  • IgE
  • NOD gene
  • polymorphism

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy


Dive into the research topics of 'Allergy to betalactams and nucleotide-binding oligomerization domain (NOD) gene polymorphisms'. Together they form a unique fingerprint.

Cite this